Traditional Chinese Medicine in Prevention and Treatment of Renal Fibrosis in Diabetic Nephropathy by Targeting Notch Signaling Pathway： A Review

WANG Yudian; ZHOU Rong; DONG Kaixuan; CHEN Xi; YU Xiaoyong

doi:10.13422/j.cnki.syfjx.20230504

您当前的位置：

首页 >

文章列表页 >

Traditional Chinese Medicine in Prevention and Treatment of Renal Fibrosis in Diabetic Nephropathy by Targeting Notch Signaling Pathway： A Review

更新时间：2023-08-07

- Traditional Chinese Medicine in Prevention and Treatment of Renal Fibrosis in Diabetic Nephropathy by Targeting Notch Signaling Pathway： A Review
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 29, Issue 17, Pages: 221-227(2023)
- 作者机构：
  
  1.陕西中医药大学，陕西咸阳 712046
  2.陕西省中医医院，西安 710003
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20230504
  CLC： R2-0;R22;R285.5;R284;R33
- Published：05 September 2023，
  
  Published Online：13 February 2023，
  
  Received：05 November 2022，
- 稿件说明：
扫描看全文
王雨典,周荣,董凯旋等.中医药靶向Notch信号通路防治糖尿病肾病肾脏纤维化研究进展[J].中国实验方剂学杂志,2023,29(17):221-227.

WANG Yudian,ZHOU Rong,DONG Kaixuan,et al.Traditional Chinese Medicine in Prevention and Treatment of Renal Fibrosis in Diabetic Nephropathy by Targeting Notch Signaling Pathway： A Review[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(17):221-227.
王雨典,周荣,董凯旋等.中医药靶向Notch信号通路防治糖尿病肾病肾脏纤维化研究进展[J].中国实验方剂学杂志,2023,29(17):221-227. DOI： 10.13422/j.cnki.syfjx.20230504.

WANG Yudian,ZHOU Rong,DONG Kaixuan,et al.Traditional Chinese Medicine in Prevention and Treatment of Renal Fibrosis in Diabetic Nephropathy by Targeting Notch Signaling Pathway： A Review[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(17):221-227. DOI： 10.13422/j.cnki.syfjx.20230504.

摘要

糖尿病肾病（DN）是世界范围内常见的慢性肾脏病（CKD）之一，也是导致终末期肾病（ESRD）的主要原因，已严重威胁且影响到全球人类的生活健康。目前认为，DN的发病是在机体持续高糖环境下，糖代谢紊乱、脂质代谢异常、氧化应激、炎症因子激活、自噬及细胞凋亡等诸多因素密切相关。肾脏纤维化是DN发展的重要病理特征和最终病理结果，对肾脏纤维化及时干预对于DN防治具有重要的临床和现实意义。因西医治疗DN的局限性，中医药干预DN肾脏纤维化的进程以其多成分、多效应、多靶点的协同作用有效延缓疾病进展，常被用作DN治疗的常规和潜在治疗方法。研究发现，Notch信号通路在机体发育和维持稳态的过程中起重要作用，Notch信号通路异常激活与DN发生相关，该信号通路的激活在肾脏纤维化进程起关键作用。文章综述了Notch信号通路在DN肾脏纤维化的调控机制，重点探讨了中药单体及中药复方靶向Notch信号通路与DN肾脏纤维化的关系，以期为中医药防治DN的新药研发、基础研究及临床应用提供一定理论依据。

Abstract

Diabetic nephropathy （DN） is one of the common chronic kidney diseases （CKD） worldwide and a major cause of end-stage renal disease （ESRD）， seriously threatening and affecting the life and health of the global population. Currently， the pathogenesis of DN is considered to be closely related to factors such as glucose metabolism disorders， abnormal lipid metabolism， oxidative stress， activation of inflammatory factors， autophagy， and cell apoptosis in the continuous high-glucose environment of the body. Renal fibrosis is an important pathological feature and ultimate pathological outcome of DN. Timely intervention in renal fibrosis is of significant clinical and practical importance for the prevention and treatment of DN. Due to the limitations of western medicine in treating DN， traditional Chinese medicine （TCM） intervention in the process of renal fibrosis in DN has been widely used as a routine and potential treatment method due to its multi-component， multi-effect， and multi-target effects， effectively delaying the progression of the disease. It has been found that the Notch signaling pathway plays an important role in the development and maintenance of homeostasis in the body， and abnormal activation of the Notch signaling pathway is associated with DN. Activation of this signaling pathway plays a key role in the process of renal fibrosis. This article reviewed the regulatory mechanism of the Notch signaling pathway in renal fibrosis in DN， focusing on the relationship between targeting Notch signaling pathway by Chinese medicinal monomers and prescriptions and renal fibrosis in DN in order to provide a theoretical basis for the development of new drugs， basic research， and clinical application of TCM in the prevention and treatment of DN.

关键词

糖尿病肾病肾脏纤维化Notch中医药信号通路综述

Keywords

diabetic nephropathyrenal fibrosisNotchtraditional Chinese medicinesignaling pathwayreview

references

UMANATH K，LEWIS J B.Update on diabetic nephropathy： Core curriculum 2018［J］.Am J Kidney Dis，2018，71（6）：884-895.

SAMSU N.Diabetic nephropathy： Challenges in pathogenesis， diagnosis， and treatment［J］.Biomed Res Int，2021，2021：1497449.

GNUDI L，COWARD R，LONG D A.Diabetic nephropathy： Perspective on novel molecular mechanisms［J］.Trends Endocrinol Metab，2016，27（11）：820-830.

SARAN R，LI Y，ROBINSON B，et al.US renal data system 2014 annual data report： Epidemiology of kidney disease in the united states［J］.Am J Kidney Dis，2015，66（1 Suppl 1）：S1-305.

XU L，LIN X，GUAN M，et al.Verapamil attenuated prediabetic neuropathy in high-fat diet-fed mice through inhibiting TXNIP-mediated apoptosis and inflammation［J］.Oxid Med Cell Longev，2019，2019：1896041.

WANG J，ZHANG Q，LI S，et al.Low molecular weight fucoidan alleviates diabetic nephropathy by binding fibronectin and inhibiting ECM-receptor interaction in human renal mesangial cells［J］.Int J Biol Macromol，2020，150：304-314.

BRENNEMAN J，HILL J，PULLEN S.Emerging therapeutics for the treatment of diabetic nephropathy［J］.Bioorg Med Chem Lett，2016，26（18）：4394-4402.

LIN Y C，CHANG Y H，YANG S Y，et al.Update of pathophysiology and management of diabetic kidney disease［J］.J Formos Med Assoc，2018，117（8）：662-675.

MUKHERJEE M，FOGARTY E，JANGA M，et al.Notch signaling in kidney development， maintenance， and disease［J］.Biomolecules，2019，9（11）：692.

MEURETTE O，MEHLEN P.Notch signaling in the tumor microenvironment［J］.Cancer Cell，2018，34（4）：536-548.

CASTRO R C，GONÇALES R A，ZAMBUZI F A，et al.Notch signaling pathway in infectious diseases： Role in the regulation of immune response［J］.Inflamm Res，2021，70（3）：261-274.

ARTAVANIS-TSAKONAS S，RAND M D，LAKE R J.Notch signaling： Cell fate control and signal integration in development［J］.Science，1999，284（5415）：770-776.

GHAFOURI-FARD S，GLASSY M C，ABAK A，et al.The interaction between miRNAs/lncRNAs and Notch pathway in human disorders［J］.Biomed Pharmacother，2021，138：111496.

PARK J S，KIM S H，KIM K，et al.Inhibition of notch signalling ameliorates experimental inflammatory arthritis［J］.Ann Rheum Dis，2015，74（1）：267-274.

ZHENG D，TAO M，LIANG X，et al.p66Shc regulates podocyte autophagy in high glucose environment through the Notch-PTEN-PI3K/Akt/mTOR pathway［J］.Histol Histopathol，2020，35（4）：405-415.

SIEBEL C，LENDAHL U.Notch signaling in development， tissue homeostasis， and disease［J］.Physiol Rev，2017，97（4）：1235-1294.

ZHOU L，XU D Y，SHA W G，et al.High glucose induces renal tubular epithelial injury via Sirt1/NF-kappaB/microR-29/Keap1 signal pathway［J］.J Transl Med，2015，13：352.

高峰，刘淑霞，赵玉峰，等.Notch信号通路在糖尿病小鼠肾组织的表达及意义［J］.中国组织化学与细胞化学杂志，2014，23（5）：445-449.

LIN Y，ZHAO J L，ZHENG Q J，et al.Notch signaling modulates macrophage polarization and phagocytosis through direct suppression of signal regulatory protein α expression［J］.Front Immunol，2018，9：1744.

BONEGIO R，SUSZTAK K.Notch signaling in diabetic nephropathy［J］.Exp Cell Res，2012，318（9）：986-992.

LIN C L，WANG F S，HSU Y C，et al.Modulation of notch-1 signaling alleviates vascular endothelial growth factor-mediated diabetic nephropathy［J］.Diabetes，2010，59（8）：1915-1925.

TUNG C W，HSU Y C，SHIH Y H，et al.Glomerular mesangial cell and podocyte injuries in diabetic nephropathy［J］.Nephrology （Carlton），2018，23（Suppl 4）：32-37.

MUREA M，PARK J K，SHARMA S，et al.Expression of Notch pathway proteins correlates with albuminuria， glomerulosclerosis， and renal function［J］.Kidney Int，2010，78（5）：514-522.

孙倩，李姗姗，杨少宁，等.中医药调控Notch信号通路防治肾脏疾病研究进展［J］.中国实验方剂学杂志，2021，27（24）：227-234.

NYHAN K C，FAHERTY N，MURRAY G，et al.Jagged/Notch signalling is required for a subset of TGF-β1 responses in human kidney epithelial cells［J］.Biochim Biophys Acta，2010，1803（12）：1386-1395.

LIU L，GAO C，CHEN G，et al.Notch signaling molecules activate TGF-β in rat mesangial cells under high glucose conditions［J］.J Diabetes Res，2013，2013：979702.

SWEETWYNE M T，TAO J，SUSZTAK K.Kick it up a Notch： Notch signaling and kidney fibrosis［J］.Kidney Int Suppl （2011），2014，4（1）：91-96.

闫璞，刘晓峰，王世东，等.吕仁和教授诊治糖尿病、糖尿病肾脏病及肾病综合征的常用药物分析［J］.世界中医药，2017，12（1）：30-33.

许成群，王元，孙永亮.糖尿病肾病“肾络瘀阻”理论及其应用［J］.中医研究，2013，26（4）：3-6.

范婷，杨晓晖，李怡，等.糖尿病肾病的中医临床研究进展［J］.北京中医药，2019，38（10）：1036-1041.

文亮亮.吕仁和教授“六对论治”消渴病肾病医案浅析［D］.北京：北京中医药大学，2016.

沈金峰，黄伟，罗富里，等.肾纤维化微型癥积中医病机探析［J］.辽宁中医杂志，2018，45（6）：1176-1178.

黄一珊，符馨文，王旭，等.从“肾络三态论”探讨糖尿病肾病的临床辨治［J］.中国中西医结合肾病杂志，2019，20（6）：559-561.

李建瑛，肇寅辉，康燕，等.姜黄素预处理对干热环境下不同程度中暑大鼠肾病理损伤及氧化应激的影响［J］.中国比较医学杂志，2018，28（11）：48-52，122.

邓文荣，石文清，李海俏，等.姜黄素对糖尿病肾病大鼠肾功能及肾组织JNK、Notch2/hes1信号通路的影响［J］.山东医药，2020，60（14）：5-8.

周瑞，项昌培，张晶晶，等.黄连化学成分及小檗碱药理作用研究进展［J］.中国中药杂志，2020，45（19）：4561-4573.

YANG G，ZHAO Z，ZHANG X，et al.Effect of berberine on the renal tubular epithelial-to-mesenchymal transition by inhibition of the Notch/snail pathway in diabetic nephropathy model KKAy mice［J］.Drug Des Devel Ther，2017，11：1065-1079.

丁建营，刘春娟，郭建军，等.天花粉化学成分的药理活性及其提取与检测方法研究进展［J］.中国药房，2018，29（13）：1859-1864.

LU J D，YANG Y L，PENG J T，et al.Trichosanthes kirilowii lectin ameliorates streptozocin-induced kidney injury via modulation of the balance between M1/M2 phenotype macrophage［J］.Biomed Pharmacother，2019，109：93-102.

LIU B，DENG C，TAN P.Ombuin ameliorates diabetic nephropathy in rats by anti-inflammation and antifibrosis involving Notch 1 and PPARγ signaling pathways［J］.Drug Dev Res，2022，83（6）：1270-1280.

朱大诚，常娜，吴慧婷.雷公藤甲素抗肿瘤机制的研究［J］.中华中医药学刊，2022，40（12）：8-12.

韩菲.雷公藤甲素通过PDK1/Akt及miR-137/Notch1通路改善糖尿病肾病的机制研究［D］.天津：天津医科大学，2018.

周雪梅，徐从书，王凯，等.益气养阴活血中药对糖尿病肾病大鼠Notch/Hes1通路与血管内皮CD34、CD144的影响［J］.南方医科大学学报，2019，39（7）：855-860.

杨冠男，赵宗江，张新雪，等.糖肾宁对糖尿病肾病KKAy小鼠的肾脏保护作用及其对Notch/Snail1信号转导通路的影响［J］.世界科学技术—中医药现代化，2017，19（6）：1057-1065.

江丹，汤海欣，姚楠，等.益气升清方对糖尿病肾病大鼠Notch信号通路的影响机制研究［J］.按摩与康复医学，2019，10（14）：48-51.

刘利飞，李雅纯，国芳，等.Notch通路在糖尿病肾病大鼠的表达及化瘀通络中药的干预作用［J］.中草药，2018，49（8）：1866-1870.

刘健辉.糖肾康颗粒对糖尿病肾脏疾病Notch1、Hes1影响的临床与实验研究［D］.合肥：安徽中医药大学，2021.

杨丽.糖肾康对DN模型大鼠血中ICAM-1、MCP-1的影响及其对气阴两虚血瘀证DN患者的治疗作用［D］.合肥：安徽中医药大学，2016.

高磊.糖肾康对DN干预作用的实验与临床研究及DN气阴两虚血瘀证动物模型的建立［D］.合肥：安徽中医药大学，2015.

阮宜敏.糖肾康颗粒对糖尿病肾脏疾病气阴两虚血瘀证患者外周血NF-κB、NF-κB p65、IκBα的影响［D］.合肥：安徽中医药大学，2014.

姜甫昇. 榛花消肾安胶囊干预实验性糖尿病大鼠足细胞转分化notch通路研究［D］.长春：长春中医药大学，2017.

CUI F，ZOU D，GAO Y，et al.通心络在糖尿病大鼠中通过抑制Notch1/Snail通路对Nephrin表达的效应［C］//中华中医药学会.第十五届国际络病学大会论文集.［出版者不详］，2019：1.

LI X B，NIU C L，CHEN W Y，et al.Effect of Danggui-Shaoyao-San-containing serum on the renal tubular epithelial-mesenchymal transition of diabetic nephropathy［J］.Curr Pharm Biotechnol，2020，21（12）：1204-1212.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Mechanism of miRNA-related Signaling Pathway Against Diabetic Nephropathy and Intervention of Traditional Chinese Medicine： A Review

Relationship Between Podocyte Autophagy and Diabetic Nephropathy and Regulation of Traditional Chinese Medicine： A Review

Traditional Chinese Medicine Regulates Notch Signaling Pathway to Prevent and Treat Renal Diseases：A Review

Treatment of Chronic Urticaria with Traditional Chinese Medicine by Regulating PI3K/Akt Molecular Pathway： A Review

Related Author

JIANG Xiaoxue

JIN Zhisheng

JIN Caiyun

CHEN Yanxu

ZHANG Boling

FU Yaoqin

Zheng-tao CHEN

Hong GAO

Related Institution

Clinical College of Chinese Medicine， Gansu University of Chinese Medicine

Hospital of Chengdu University of Traditional Chinese Medicine（TCM）

TCM Regulating Metabolic Diseases Key Laboratory of Sichuan Province

First Affiliated Hospital of Army Medical University

The First School of Clinical Medicine of Shaanxi University of Chinese Medicine

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰